e-Drug3D 842 |
cas 85622-93-1 |
CLASS ANTINEOPLASTIC |
ROUTE (list) ORAL INTRAVENOUS |
ATC code |
PK parameters F 100 PERCENT |
Target TARGET DNA |
DrugCentral Unknown |
Download SDF file | 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide Formula: Calculated chemical properties: MW 194.17 NB_atoms 14 XLogP -2.08 PSA 101.461 NB_HD 2 NB_HA 8 fsp3 0.17 Lipinski(0=no;1=yes) 1 |
FDA NDA 021029 (label) INN (TEMOZOLOMIDE) TEMODAR (MERCK SHARP DOHME) APPROVAL= AP YEAR= 1999 DISCONTINUED NDA 022277 (label) INN (TEMOZOLOMIDE) TEMODAR (MERCK SHARP DOHME) APPROVAL= AP YEAR= 2009 NDA 078879 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (HERITAGE) APPROVAL= AP YEAR= 2010 DISCONTINUED NDA 201742 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (SUN PHARM) APPROVAL= AP YEAR= 2014 NDA 203691 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2015 NDA 205227 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (EXTROVIS) APPROVAL= AP YEAR= 2016 DISCONTINUED NDA 203898 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (EIRGEN) APPROVAL= AP YEAR= 2016 NDA 206309 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (RISING) APPROVAL= AP YEAR= 2016 NDA 206413 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (CHARTWELL) APPROVAL= AP YEAR= 2016 NDA 203490 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (ANI PHARMS) APPROVAL= AP YEAR= 2016 DISCONTINUED NDA 204639 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (CHEMI SPA) APPROVAL= AP YEAR= 2016 NDA 201528 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2017 NDA 203959 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (WATSON LABS TEVA) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 206750 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2017 NDA 207658 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (DEVA HOLDING AS) APPROVAL= AP YEAR= 2017 NDA 204159 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (APOTEX) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 213328 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (NIVAGEN PHARMS INC) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 210030 (pdf not found) INN (TEMOZOLOMIDE) TEMOZOLOMIDE (HETERO LABS LTD V) APPROVAL= AP YEAR= 2024 |
Other links: |